Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Apr:75:102447.
doi: 10.1016/j.coph.2024.102447. Epub 2024 Mar 11.

Targeting TRP channels for pain relief: A review of current evidence from bench to bedside

Affiliations
Free article
Review

Targeting TRP channels for pain relief: A review of current evidence from bench to bedside

Ari-Pekka Koivisto et al. Curr Opin Pharmacol. 2024 Apr.
Free article

Abstract

Several decades of research support the involvement of transient receptor potential (TRP) channels in nociception. Despite the disappointments of early TRPV1 antagonist programs, the TRP family remains a promising therapeutic target in pain disorders. High-dose capsaicin patches are already in clinical use to relieve neuropathic pain. At present, localized injections of the side-directed TRPV1 agonist capsaicin and resiniferatoxin are undergoing clinical trials in patients with osteoarthritis and bone cancer pain. TRPA1, TRPM3, and TRPC5 channels are also of significant interest. This review discusses the role of TRP channels in human pain conditions.

PubMed Disclaimer

Conflict of interest statement

Declaration of competing interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Ari-Pekka Koivisto is an employee of Orion Pharma. Thomas Voets has an interest in the TRPM3 antagonist program at Biohaven Pharmaceuticals. Michael J. Iadarola and Arpad Szallasi have no conflict of interest to declare.

LinkOut - more resources